GGrantIndex
Sort

261,768 grants matching gene therapy

Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum

$1,151,816
Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2025 · AG

Core B: Industrialization Core

$1,151,790
Kartik Chandran · Albert Einstein College Of Medicine · U19 · FY2023 · AI

Molecular Mechanisms Of Glaucoma

$1,151,784
Stanislav I Tomarev · National Eye Institute · ZIA · FY2015 · EY

Nuclear Structure and Gene Expression

$1,151,740
Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2007 · CA

Immune Regulation in HCT

$1,151,709
Robert S Negrin · Stanford University · P01 · FY2017 · CA

Immune Regulation in HCT

$1,151,707
Robert S Negrin · Stanford University · P01 · FY2016 · CA

Immune Regulation in HCT

$1,151,707
Robert S Negrin · Stanford University · P01 · FY2015 · CA

HCMR Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

$1,151,474
Christopher M Kramer · University Of Virginia · U01 · FY2015 · HL

Biochemical Analysis of Multidrug Resistance-linked Transport Proteins

$1,151,394
Suresh Ambudkar · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response

$1,151,331
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression

$1,151,331
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Genetics, Pathophysiology, and Treatment of Dominant Autoinflammatory Diseases

$1,151,045
Daniel Kastner · National Human Genome Research Institute · ZIA · FY2011 · HG

Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory Diseases

$1,151,045
Daniel Kastner · National Human Genome Research Institute · ZIA · FY2011 · HG

Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer

$1,151,039
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis

$1,151,039
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

GENE THERAPY FOR CYSTIC FIBROSIS AND OTHER GENETIC DISEA

$1,151,000
University Of Pennsylvania · P30 · FY2002 · DK

GENE THERAPY FOR CYSTIC FIBROSIS AND OTHER GENETIC DISEA

$1,151,000
University Of Pennsylvania · P30 · FY2001 · DK

GENE THERAPY FOR CYSTIC FIBROSIS AND OTHER GENETIC DISEA

$1,151,000
University Of Pennsylvania · P30 · FY2000 · DK

Preclinical drug development in pancreatic cancer

$1,150,996
Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Oral Delivery Vehicles for RNAi Therapies

$1,150,827
Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R01 · FY2013 · DK

Specialized Center of Research in Scleroderma

$1,150,816
University Of Texas Hlth Sci Ctr Houston · P50 · FY2001 · AR

Center for Neurovisceral Sciences & Women's Health

$1,150,718
Emeran A Mayer · University Of California Los Angeles · P50 · FY2009 · DK

Expansion of cardiac and hematopoietic progenitors by Wnt and Notch

$1,150,678
Edward E Morrisey · University Of Pennsylvania · U01 · FY2015 · HL

Role of Neurotrophins in the Development of the Mammalian Nervous System

$1,150,610
Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Novel small-molecule therapies for CF

$1,150,450
Alan S Verkman · University Of California, San Francisco · P30 · FY2015 · DK